Literature DB >> 23129592

Approach to the child with prader-willi syndrome.

Jennifer L Miller1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23129592      PMCID： PMC3485601          DOI： 10.1210/jc.2012-2543

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN： 0021-972X            Impact factor:   5.958


× No keyword cloud information.
  57 in total

1.  The relationship between IGF-I concentration, cognitive function and quality of life in adults with Prader-Willi syndrome.

Authors:  I C van Nieuwpoort; J B Deijen; L M G Curfs; M L Drent
Journal:  Horm Behav       Date:  2011-01-08       Impact factor: 3.587

2.  Efficacy of modafinil on excessive daytime sleepiness in Prader-Willi syndrome.

Authors:  V Cochen De Cock; G Diene; C Molinas; V Dauriac-Le Masson; I Kieffer; E Mimoun; M Tiberge; M Tauber
Journal:  Am J Med Genet A       Date:  2011-06-10       Impact factor: 2.802

3.  Growth hormone treatment for two years is safe and effective in adults with Prader-Willi syndrome.

Authors:  Rasmus Sode-Carlsen; Stense Farholt; Kai Fr Rabben; Jens Bollerslev; Thomas Schreiner; Anne Grethe Jurik; Jan Frystyk; Jens Sandahl Christiansen; Charlotte Höybye
Journal:  Growth Horm IGF Res       Date:  2011-06-12       Impact factor: 2.372

4.  Beneficial effects of growth hormone treatment on cognition in children with Prader-Willi syndrome: a randomized controlled trial and longitudinal study.

Authors:  Elbrich P C Siemensma; Roderick F A Tummers-de Lind van Wijngaarden; Dederieke A M Festen; Zyrhea C E Troeman; A A E M Janielle van Alfen-van der Velden; Barto J Otten; Joost Rotteveel; Roelof J H Odink; G C B Karen Bindels-de Heus; Mariette van Leeuwen; Danny A J P Haring; Wilma Oostdijk; Gianni Bocca; E C A Mieke Houdijk; A S Paul van Trotsenburg; J J Gera Hoorweg-Nijman; Hester van Wieringen; René C F M Vreuls; Petr E Jira; Eelco J Schroor; Evelyn van Pinxteren-Nagler; Jan Willem Pilon; L Bert Lunshof; Anita C S Hokken-Koelega
Journal:  J Clin Endocrinol Metab       Date:  2012-04-16       Impact factor: 5.958

Review 5.  Prader-Willi syndrome: clinical genetics, cytogenetics and molecular biology.

Authors:  Douglas C Bittel; Merlin G Butler
Journal:  Expert Rev Mol Med       Date:  2005-07-25       Impact factor: 5.600

6.  Hypogonadism in females with Prader-Willi syndrome from infancy to adulthood: variable combinations of a primary gonadal defect and hypothalamic dysfunction.

Authors:  Talia Eldar-Geva; Harry J Hirsch; Fortu Benarroch; Orit Rubinstein; Varda Gross-Tsur
Journal:  Eur J Endocrinol       Date:  2009-11-27       Impact factor: 6.664

7.  Growth hormone and body composition in children younger than 2 years with Prader-Willi syndrome.

Authors:  Urs Eiholzer; Dagmar L'allemand; Michael Schlumpf; Valentin Rousson; Theo Gasser; Christoph Fusch
Journal:  J Pediatr       Date:  2004-06       Impact factor: 4.406

8.  Growth hormone treatment of adults with Prader-Willi syndrome and growth hormone deficiency improves lean body mass, fractional body fat, and serum triiodothyronine without glucose impairment: results from the United States multicenter trial.

Authors:  Harriette R Mogul; Phillip D K Lee; Barbara Y Whitman; William B Zipf; Michael Frey; Susan Myers; Mindy Cahan; Belinda Pinyerd; A Louis Southren
Journal:  J Clin Endocrinol Metab       Date:  2008-01-22       Impact factor: 5.958

9.  Hypogonadism and pubertal development in Prader-Willi syndrome.

Authors:  A Crinò; R Schiaffini; P Ciampalini; S Spera; L Beccaria; F Benzi; L Bosio; A Corrias; L Gargantini; A Salvatoni; G Tonini; G Trifirò; C Livieri
Journal:  Eur J Pediatr       Date:  2003-02-27       Impact factor: 3.183

10.  Randomized controlled trial to investigate the effects of growth hormone treatment on scoliosis in children with Prader-Willi syndrome.

Authors:  Roderick F A de Lind van Wijngaarden; Luuk W L de Klerk; Dederieke A M Festen; Hugo J Duivenvoorden; Barto J Otten; Anita C S Hokken-Koelega
Journal:  J Clin Endocrinol Metab       Date:  2009-01-21       Impact factor: 5.958
View more
  17 in total

Review 1.  Review of Prader-Willi syndrome: the endocrine approach.

Authors:  Ryan Heksch; Manmohan Kamboj; Kathryn Anglin; Kathryn Obrynba
Journal:  Transl Pediatr       Date:  2017-10

2.  Does the Genetic Cause of Prader-Willi Syndrome Explain the Highly Variable Phenotype?

Authors:  Andreea-Iulia Dobrescu; Adela Chirita-Emandi; Nicoleta Andreescu; Simona Farcas; Maria Puiu
Journal:  Maedica (Bucur)       Date:  2016-09

Review 3.  Evaluation and Management of Early Onset Genetic Obesity in Childhood.

Authors:  Sonali Malhotra; Ramya Sivasubramanian; Gitanjali Srivastava
Journal:  J Pediatr Genet       Date:  2021-07-03

4.  Hypothalamic loss of Snord116 and Prader-Willi syndrome hyperphagia: the buck stops here?

Authors:  Juan A Rodriguez; Jeffrey M Zigman
Journal:  J Clin Invest       Date:  2018-01-29       Impact factor: 14.808

Review 5.  Delayed and Precocious Puberty: Genetic Underpinnings and Treatments.

Authors:  Anisha Gohil; Erica A Eugster
Journal:  Endocrinol Metab Clin North Am       Date:  2020-12       Impact factor: 4.741

6.  Correlation of Genotype and Perinatal Period, Time of Diagnosis and Anthropometric Data before Commencement of Recombinant Human Growth Hormone Treatment in Polish Patients with Prader-Willi Syndrome.

Authors:  Agnieszka Lecka-Ambroziak; Marta Wysocka-Mincewicz; Katarzyna Doleżal-Ołtarzewska; Agata Zygmunt-Górska; Teresa Żak; Anna Noczyńska; Dorota Birkholz-Walerzak; Renata Stawerska; Maciej Hilczer; Monika Obara-Moszyńska; Barbara Rabska-Pietrzak; Elżbieta Gołębiowska; Adam Dudek; Elżbieta Petriczko; Mieczysław Szalecki
Journal:  Diagnostics (Basel)       Date:  2021-04-28

7.  Characteristics and relationship between hyperphagia, anxiety, behavioral challenges and caregiver burden in Prader-Willi syndrome.

Authors:  Nathalie Kayadjanian; Caroline Vrana-Diaz; Jessica Bohonowych; Theresa V Strong; Josée Morin; Diane Potvin; Lauren Schwartz
Journal:  PLoS One       Date:  2021-03-25       Impact factor: 3.240

Review 8.  Syndromic disorders with short stature.

Authors:  Zeynep Şıklar; Merih Berberoğlu
Journal:  J Clin Res Pediatr Endocrinol       Date:  2014

9.  Ghrelin Receptor Agonist Rescues Excess Neonatal Mortality in a Prader-Willi Syndrome Mouse Model.

Authors:  Juan A Rodriguez; Emily C Bruggeman; Bharath K Mani; Sherri Osborne-Lawrence; Caleb C Lord; Henry F Roseman; Hannah L Viroslav; Prasanna Vijayaraghavan; Nathan P Metzger; Deepali Gupta; Kripa Shankar; Claudio Pietra; Chen Liu; Jeffrey M Zigman
Journal:  Endocrinology       Date:  2018-12-01       Impact factor: 4.736

10.  Endocrine manifestations and management of Prader-Willi syndrome.

Authors:  Jill E Emerick; Karen S Vogt
Journal:  Int J Pediatr Endocrinol       Date:  2013-08-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.